Apollo Group Advances Strategic Restructuring with Secured Creditors Meeting Set for June 2026

Apollo Group Advances Strategic Restructuring with Secured Creditors Meeting Set for June 2026​

Apollo Hospitals Enterprise Ltd is undertaking a significant corporate restructuring through a composite scheme of arrangement involving itself, Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited. The secured creditors of Apollo Hospitals Enterprise Ltd have been called to a special meeting to consider and approve the comprehensive scheme, which includes a demerger and two amalgamations, as directed by various orders from the National Company Law Tribunal (NCLT).

The tripartite process aims to restructure operations across the involved companies, with the Identified Business Undertaking of Apollo Hospitals Enterprise Ltd being carved out into the Resultant Company, Apollo Healthtech Limited. This move is intended to allow both entities—the Demerged Company and the new Resultant Company—to focus efficiently on their respective businesses and market opportunities.

The scheme entails several key corporate changes:

• Demerger: The Identified Business Undertaking of Apollo Hospitals Enterprise Ltd will be demerged into Apollo Healthtech Limited, leading to the issuance of fully paid-up equity shares of the Resultant Company to eligible shareholders of the Demerged Company based on a pre-defined share entitlement ratio.
• Amalgamations: Transferor Company 1 (Apollo Healthco Limited) and Transferor Company 2 (Keimed Private Limited) will be amalgamated into Apollo Healthtech Limited, leading to the issuance of equity shares in the Resultant Company to eligible shareholders of these transferor companies upon their respective record dates.
• Operational Changes: The scheme also includes the re-categorisation of authorized preference share capital and involves changes to the articles of association of Apollo Healthtech Limited.

The boards of directors of all four entities—Apollo Hospitals Enterprise Ltd, Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited—unanimously approved the Scheme during their respective meetings in June 2025.

Strategic Rationale and Business Impact​

The boards of directors have determined that the scheme is commercially viable and serves the best interest of all stakeholders. The primary benefits include:

• Focused Growth: Enabling the carving out of the Identified Business Undertaking from Apollo Hospitals Enterprise Ltd to allow specialized focus, efficient management, and control in the Resultant Company.
• Consolidation and Synergy: Consolidating the pharmacy distribution business of Transferor Company 1 and Transferor Company 2 into an independent entity focused on digital health and pharmacy distribution, thereby generating synergies.
• Market Expansion: Preparing the Resultant Company to build a wider capital and financial base by attracting strategic partners and investors.

The overall impact is projected to significantly influence Apollo Hospitals Enterprise Ltd's future revenue generation capacity, with expected revenues forecast for the Demerged Company reaching INR 195.2 crores for the financial year ending March 31, 2027, and increasing toward INR 492.80 crores by March 31, 2030.

Financial Standing of Creditors​

The scheme addresses the financial standing of creditors across all involved companies. As of December 31, 2025, the unsecured liabilities are as follows:


For secured creditors of Apollo Hospitals Enterprise Ltd alone, the outstanding amount as of December 31, 2025 stands at INR 173,79,385,616.

Creditor Meeting and E-voting Details​

A meeting for the secured creditors of Apollo Hospitals Enterprise Limited is scheduled to be held on Wednesday, June 24, 2026, at 10:00 a.m. IST through Video Conferencing (VC)/Other Audio Visual Means (OAVM). This meeting is intended to consider and approve the composite scheme of arrangement.

The mechanism for secured creditors to vote includes two stages:
1. Remote E-voting: The period for remote e-voting begins on Saturday, June 20, 2026, at 9:00 a.m. IST and concludes on Tuesday, June 23, 2026, at 5:00 p.m. IST.
2. E-voting during the Meeting: Creditors who do not exercise their voting rights during the remote e-voting period will have the opportunity to vote through the e-voting facility provided at the meeting on June 24, 2026.

The voting rights of secured creditors are determined by their debt in Apollo Hospitals Enterprise Ltd as recorded on December 31, 2025. The Scheme stipulates that approval requires a requisite majority of persons representing three-fourths in value of the secured creditors, achieved through either remote e-voting or during the meeting.

APOLLOHOSP Stock Price Movement​

Shares of Apollo Hospitals Enterprise Limited are edging higher to ₹8309.5 as of 10:17 AM today, after gaining 0.73%. The stock is seeing significant activity in live trading, with 46,872 shares traded so far.